Comment on

• The price tag on progress--chemotherapy for colorectal cancer.

  Schrag D. Schrag D. N Engl J Med. 2004 Jul 22;351(4):317-9. doi: 10.1056/NEJMp048143. N Engl J Med. 2004. PMID: 15269308 No abstract available.
• Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

  Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E. Cunningham D, et al. N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025. N Engl J Med. 2004. PMID: 15269313 Clinical Trial.